309 related articles for article (PubMed ID: 16209021)
1. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
[No Abstract] [Full Text] [Related]
2. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype.
Toungoussova OS; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):281-90. PubMed ID: 15477041
[TBL] [Abstract][Full Text] [Related]
3. [Drug resistance characterization on Beijing family of Mycobacterium tuberculosis].
Guo YL; Liu Y; Wang SM
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):306-7. PubMed ID: 19642395
[No Abstract] [Full Text] [Related]
4. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.
van Crevel R; Nelwan RH; de Lenne W; Veeraragu Y; van der Zanden AG; Amin Z; van der Meer JW; van Soolingen D
Emerg Infect Dis; 2001; 7(5):880-3. PubMed ID: 11747703
[TBL] [Abstract][Full Text] [Related]
5. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype.
Mokrousov I; Jiao WW; Sun GZ; Liu JW; Valcheva V; Li M; Narvskaya O; Shen AD
Antimicrob Agents Chemother; 2006 Aug; 50(8):2820-3. PubMed ID: 16870777
[TBL] [Abstract][Full Text] [Related]
6. [Bactericidal therapy in patients with tuberculosis].
Krasnov VA; Ursov IG
Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
[No Abstract] [Full Text] [Related]
7. Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.
Baranov AA; Mariandyshev AO; Mannsåker T; Dahle UR; Bjune GA
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1288-93. PubMed ID: 19793435
[TBL] [Abstract][Full Text] [Related]
8. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance and fitness in Mycobacterium tuberculosis infection.
Bottger EC; Pletschette M; Andersson D
J Infect Dis; 2005 Mar; 191(5):823-4; author reply 824. PubMed ID: 15688309
[No Abstract] [Full Text] [Related]
10. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
[TBL] [Abstract][Full Text] [Related]
11. Beijing/W Mycobacterium tuberculosis in Italy.
Lari N; Rindi L; Bonanni D; Tortoli E; Garzelli C
Emerg Infect Dis; 2004 May; 10(5):958-9. PubMed ID: 15216844
[No Abstract] [Full Text] [Related]
12. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria.
Valcheva V; Mokrousov I; Narvskaya O; Rastogi N; Markova N
Infect Genet Evol; 2008 Sep; 8(5):657-63. PubMed ID: 18657631
[TBL] [Abstract][Full Text] [Related]
13. [Genotypic and phenotypic methods for testing Mycobacterium tuberculosis sensitivity to antibiotics].
Melinte V
Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):67-88. PubMed ID: 19856846
[No Abstract] [Full Text] [Related]
14. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
Novozhilova IA
Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
[No Abstract] [Full Text] [Related]
15. Drug resistance among Mycobacterium tuberculosis strains in immigrants: is there a real threat everywhere?
Esteban J; Granizo JJ; Alvarez-Castillo MC; Soriano F
Clin Microbiol Infect; 2004 Apr; 10(4):335-6. PubMed ID: 15059124
[TBL] [Abstract][Full Text] [Related]
16. [Secondary drug resistance of Mycobacterium tuberculosis in coniotuberculosis and pulmonary tuberculosis].
Beskrovnyĭ PS; Varenko IuS; Revenko TA; Khokhlov VN
Probl Tuberk; 1976 Jul; (7):66-70. PubMed ID: 822417
[No Abstract] [Full Text] [Related]
17. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones.
Yew WW; Chan E; Chan CY; Cheng AF
Int J Tuberc Lung Dis; 2002 Oct; 6(10):936-7. PubMed ID: 12365583
[No Abstract] [Full Text] [Related]
18. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
[No Abstract] [Full Text] [Related]
19. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA
Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biological assays in phthisiology].
Skotnikova OI
Probl Tuberk Bolezn Legk; 2005; (8):5-10. PubMed ID: 16209010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
